Workflow
蓝丰生化200名投资者诉讼索赔案执行完毕 赔付金额达2373.80万元

Group 1 - The core point of the article is that Jiangsu Lanfeng Biological Chemical Co., Ltd. has completed the execution of a lawsuit involving compensation claims from 200 investors, with a total compensation amount of approximately 23.738 million yuan [1][2] - The company has disclosed the details of the lawsuit, including the final judgment from Jiangsu High People's Court and the civil ruling and judgment from Nanjing Intermediate People's Court regarding the claims of 163 investors and 45 investors respectively [1][2] - The company has fulfilled all obligations related to the lawsuit, and all asset preservation and freezing measures have been lifted, with relevant bank accounts also unfrozen [1][2] Group 2 - The total compensation amount and related costs for the lawsuit are approximately 23.738 million yuan, which includes compensation for the lawsuit, litigation fees, case acceptance fees, execution fees, and overdue payment penalties [2] - The company will process the financial implications of the lawsuit according to relevant accounting standards, with the specific amount subject to audit results [2]